Trial Profile
A safety and efficacy trial of sorafenib with transarterial chemoembolization (TACE) for the treatment of hepato-cellular carcinoma in patients with portal venous tumour thrombus (PVTT)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record